期刊文献+

不同水化方案预防冠状动脉介入术后造影剂肾病的临床研究 被引量:10

Preventive effect of four kinds of hydration therapy on contrast-induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention
下载PDF
导出
摘要 目的 探讨不同水化方案对冠状动脉介入诊疗术后造影剂肾病(CIN)的预防作用.方法 选择2010年10月至2011年10月在北京安贞医院行冠状动脉造影或介入治疗的627例患者作为研究对象,完全随机分为生理盐水组(161例)、碳酸氢钠组(159例)、生理盐水加N-乙酰半胱氨酸(NAC)口服组(157例)和碳酸氢钠加NAC口服组(150例).所有患者均使用低渗非离子型造影剂.观察各组CIN的发生情况.结果 CIN总发生率为4.47% (28/627),生理盐水组、碳酸氢钠组、生理盐水+NAC口服组、碳酸氢钠+NAC口服组的CIN发生率分别为2.48%(4/161)、4.40% (7/159)、5.10% (8/157)、6.00% (9/150),差异无统计学意义(P =0.483);在糖尿病合并肾功能不全患者中,应用不同干预方式的4组CIN发生率间差异无统计学意义(分别为2/6、3/5、2/7、2/10,P =0.493).结论 生理盐水、碳酸氢钠及NAC对于降低CIN发生率无明显差异,但在糖尿病合并肾功能不全的高危患者中,碳酸氢钠联合NAC可能优于单独应用等渗晶体液水化,有降低CIN发生的趋势. Objective To observe the preventive effect of application of sodium chloride, sodium bicarbon- ate, sodium chloride plus N-acetylcysteine (NAC) and sodium bicarbonate plus NAC on contrast agent-induced nephrotoxicity (CIN) in patients undergoing coronary angiography and/or percutaneous coronary intervention (PCI). Methods All 627 cases of coronary angiography and/or PCI from October 2010 to October 2011 were ran- domly divided into four groups: sodium chloride group ( n = 161 ), sodium bicarbonate group ( n = 159), sodium chloride plus NAC group ( n = 157), sodium bicarbonate plus NAC group ( n = 150). All these patients used the low-osmolar nonionic contrast medium. The incidence of CIN were observed and analyzed. Results Of the 627 patients, 28 experienced CIN, and the overall incidence was 4. 47% (28/627). CIN occurred in 4 patients (2.48%) in the sodium chloride group, 7 patients (4. 40% ) in the sodium bicarbonate group, 8 patients (5.10%) in the sodium chloride plus NAC group and 9 patients (6. 00% ) in the sodium bicarbonate plus NAC group(P =0. 483). Among diabetes complicated with renal insufficiency patients, CIN incidence was not statistically significant in four interventions groups (2/6, 3/5, 2/7, 2/10 respectively,P = 0. 493 ). Conclusions Sodium chloride, sodium bicar-bonate and NAC for reducing the incidence of CIN have no significant difference. In diabetes mellitus complicated with renal dysfunction, the efficacy of sodium bicarbonate plus NAC in preventing CIN is high but there is no significant difference among four groups.
机构地区 [
出处 《中国医药》 2012年第6期702-705,共4页 China Medicine
关键词 冠状动脉造影 经皮冠状动脉介入术 造影剂肾病 水化治疗 碳酸氢钠 N-乙酰半胱氨酸 Coronary angiography Pereutaneous coronary intervention Contrast-induced nephropathy Hydration therapy Sodium bicarbonate N-acetylcysteine
  • 相关文献

参考文献30

  • 1Solomon RJ,Mehran R,Natarajan MK. Contrast-induced nephropathy and long-term adverse events:cause and effect[J].Clin J Am Soc Nephro1,2009,(07):1162-1169.
  • 2Liistro F,Falsini G,Bolognese L. The clinical burden of contrast media-induced nephropathy[J].Italian Heart Journal:Official Journal of the Italian Federation of Cardiology,2003,(10):668-676.
  • 3Briguori C,Airoldi F,Morici N. New pharmacological protocols to prevent or reduce contrast media nephropathy[J].Minerva Cardioangiologica,2005,(01):49-58.
  • 4Thomsen HS. European Society of Urogenital Radiology guidelines on contrast media application[J].Current Opinion in Urology,2007,(01):70-76.doi:10.1097/MOU.0b013e328011c96f.
  • 5Ma YC,Zuo L,Chen JH. Modified glomerudar filtration rate estimating equation for Chinese patients with chronic kidney disease[J].Journal of the American Society of Nephrology,2006,(10):2937-2944.doi:10.1681/ASN.2006040368.
  • 6National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification[J].American Journal of Kidney Diseases,2002,(2 Suppl 1):S1-S266.
  • 7Lameire N,Adam A,Becker CR. Baseline renal function screening[J].American Journal of Cardiology,2006,(6A):21K-26K.
  • 8Levine GN,Bates ER,Blankenship JC. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention.A report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions[J].Journal of the American College of Cardiology,2011,(24):e44-e122.doi:10.1016/j.jacc.2011.08.006.
  • 9冠心病介入诊疗对比剂应用专家共识[J].中国心血管病研究,2010,8(12):881-889. 被引量:65
  • 10Merten GJ,Burgess WP,Rittase RA. Prevention of contrast-induced nephropathy with sodium bicarbonate:an evidence-based protocol[J].Crit Pathw Cardiol,2004,(03):138-143.doi:10.1097/01.hpc.0000137152.52554.76.

二级参考文献65

  • 1车丽燕,李永春.乌司他丁治疗急性肺损伤的研究进展[J].实用药物与临床,2006,9(5):322-324. 被引量:14
  • 2郑伟华,宁晔,汪新良,蒋崇慧,尹刚,杨伟东,龙丽珊.乌司他丁对急危重症患者多器官功能障碍的阻断作用研究[J].中国综合临床,2007,23(1):28-30. 被引量:7
  • 3汪斌,刘志忠,张丰富.冠状动脉介入诊治中高敏C反应蛋白与造影剂肾病的相关性分析[J].中国医药,2007,2(8):457-459. 被引量:35
  • 4Klein LW,Sheldon MW,Brinker J,et al.The use of radiographic contrast media during PCI:a focused review:a position statement of the Society of Cardiovascular Angiography and Interventions.Catheter Cardiovasc Interv,2009,74:728-746.
  • 5ESC Guidelines for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes.Chapter Contrast-Induced Nephropathy.Bassand et al.Eur Heart,2007,28:1598-1660.
  • 6中国医师协会心血管内科医师分会,中国医师协会循证医学专业委员会,中国老年学学会心脑血管病专业委员会.心血管疾病防治指南和共识2009.北京:人民卫生出版社,2009.
  • 7Singh J,Daftary A.Iodinated contrast media and their adverse reactions.J Nucl Med Technol,2008,36:69-74.
  • 8Nash K,Hafeez A,Hou S.Hospital-acquired renal insufficiency.Am J Kidney Dis,2002,39:930-936.
  • 9European Society of Urogential Radiology.Guidelines on Contrast Media.Version 6.0,2007.
  • 10McCullough PA,Wolyn R,Rocher LL,et al.Acute renal failure after coronary intervention:incidence,risk factors,and relationship to mortality.Am J Med,1997,103:368-375.

共引文献66

同被引文献100

引证文献10

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部